How to manage hypoglycemia (low blood sugar) in a non-diabetic patient after dialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hypoglycemia in Non-Diabetic Dialysis Patients

Non-diabetic dialysis patients experiencing hypoglycemia should be dialyzed with glucose-containing dialysate (100 mg/dL glucose concentration) rather than glucose-free dialysate, as this significantly reduces hypoglycemic episodes while maintaining stable glycemic control. 1, 2

Understanding the Problem

Hypoglycemia occurs frequently in non-diabetic dialysis patients, with studies showing that 25-31% of non-diabetic ESRD patients develop hypoglycemic episodes during hemodialysis when glucose-free dialysate is used 1, 3. The mechanisms driving this include:

  • Decreased gluconeogenesis by the kidneys, which normally contribute significantly to glucose production 4, 5
  • Glucose loss into the dialysate, averaging 7-9 grams per hour with glucose-free solutions 6, 1
  • Impaired counterregulatory hormone responses to hypoglycemia in ESRD patients 4, 2
  • Nutritional deprivation common in dialysis patients 4, 5

Importantly, these hypoglycemic episodes are often asymptomatic, with patients showing no clinical symptoms despite plasma glucose falling below 72 mg/dL 2. The hormonal response to hypoglycemia is blunted in dialysis patients, with no significant changes in glucagon, cortisol, or catecholamines even during documented hypoglycemia 2.

Immediate Management Strategy

Dialysate Modification (Primary Intervention)

Switch to glucose-containing dialysate at 100 mg/dL concentration, which reduces hypoglycemic episodes by 77% (from 22 episodes to 5 episodes in one study) and decreases time spent in hypoglycemia from 48% to 23% of the 24-hour period on dialysis days 1. This intervention:

  • Stabilizes plasma glucose within the fasting reference range 2
  • Reduces glucose loss in effluent fluid from 7.08 g/h to 5.91 g/h 1
  • Prevents the intensity and frequency of hypoglycemic episodes 1

Intradialytic Nutritional Support

Provide carbohydrate-rich snacks during dialysis for patients who experience hypoglycemia, particularly those with pre-dialysis glucose levels ≤100 mg/dL 7, 3. This corrective measure, combined with dialysate modification, reduced hypoglycemia recurrence from 46.5% to 15% in subsequent dialysis sessions 3.

Diagnostic Evaluation for Recurrent Hypoglycemia

When hypoglycemia persists despite dialysate modification, systematically evaluate for:

Common Non-Diabetic Causes

  • Adrenal insufficiency - among the most common causes in non-diabetic ESRD patients 5
  • Medications - review all medications for hypoglycemic potential, including inadvertent exposure to antidiabetic agents 5
  • Malnutrition - assess nutritional status carefully, as dialysis patients already have specific dietary requirements 8, 5
  • Infection - consider as a precipitating factor 5

Critical Pitfall to Avoid

Exclude inadvertent use of hypoglycemic agents first before pursuing extensive workup for other causes 5. This includes verifying that family members or caregivers are not diabetic and that medications are not being confused.

Monitoring Approach

Timing of Glucose Monitoring

Monitor blood glucose at specific intervals: pre-dialysis, at 1 hour, 2 hours, and 4 hours during dialysis, and in the post-dialysis period 6, 1. Continuous glucose monitoring (CGM) is superior to point-of-care testing for detecting asymptomatic hypoglycemia 4, 1.

Target Glucose Levels

Maintain fasting blood glucose levels of 110-130 mg/dL rather than aggressive targets, as this range minimizes hypoglycemia risk while avoiding complications 4, 7. Patients with initial plasma glucose ≤100 mg/dL who do not eat during dialysis are at particularly high risk 2.

Special Considerations

Post-Dialysis Period

Be vigilant for delayed hypoglycemia in the hours following dialysis, as glucose levels reach their lowest point at the end of the dialysis session 4. The day after dialysis may require particular attention to nutritional intake 7.

Patient Education

Educate patients on self-monitoring of blood glucose and recognition of hypoglycemia symptoms, though recognize that symptoms may be blunted or absent in this population 5, 2. Referral to a diabetes specialist may be warranted for recurrent episodes despite corrective measures 5.

Nutritional Assessment

Evaluate weight changes carefully, as they may require adjustment of dry weight targets for dialysis 8, 9. Malnutrition is both a cause and consequence of recurrent hypoglycemia in dialysis patients 5.

References

Research

Evaluation of glycemic status during the days of hemodialysis using dialysis solutions with and without glucose.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2018

Research

Hemodialysis and effect of corrective measures to prevent hypoglycemia.

The Journal of the Association of Physicians of India, 2022

Guideline

Insulin Requirements in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2016

Research

Plasma insulin is removed by hemodialysis: evaluation of the relation between plasma insulin and glucose by using a dialysate with or without glucose.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2007

Guideline

Management of Type 2 Diabetes in Patients on Dialysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Chyluria in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.